Global Corporate Venturing covered Antidote's funding announcement on its website. The article shares:
"Merck Global Health Innovation Fund (GHI), a subsidiary of US-based pharmaceutical firm Merck & Co., agreed on Friday to lead an $11m funding round for UK-based clinical testing access developer Antidote Technologies."
Read more at Global Corporate Venturing.
